The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ELCC 2019 | The LUNAR study: TTFields for NSCLC

Name: The LUNAR study: TTFields for NSCLC
Uploaded: 2019-04-01T00:00:00.000Z
Duration: 48 s
Description: Here Ori Farber, MD, of Novocure, Haifa, Israel, gives a background of the ongoing LUNAR study (NCT02973789) using tumor treating fields (TTF) to treat patients with non-small cell lung cancer (NSCLC) following progression while on or after platinum based treatment. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Ori Farber • 1 Apr 2019

ELCC 2019

Lung Cancer Non-Small Cell Lung Cancer

LUNAR

Here Ori Farber, MD, of Novocure, Haifa, Israel, gives a background of the ongoing LUNAR study (NCT02973789) using tumor treating fields (TTF) to treat patients with non-small cell lung cancer (NSCLC) following progression while on or after platinum based treatment. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.